Abstract
Ten biopharmaceuticals gained marketing approval in the US and EU in 2005, although only five were genuinely new molecular entities.
Original language | English |
---|---|
Pages (from-to) | 58-68 |
Number of pages | 11 |
Journal | BioPharm International |
Volume | 19 |
Issue number | 8 |
Publication status | Published - Aug 2006 |